cancer markers and prediction of treatment and managments of cancer patients?

Which specific multi-omic configurations of cancer stem cell (CSC) markers—such as OCT4, Nanog, and NOX2—are most reliable for predicting clinical resistance to immune checkpoint inhibitors in solid tumors?"

Post an Answer

Sign In to Answer

There are currently no answers.

Can 13-multiplex cytokine profiles predict early-stage CRS and irAEs in immunoncology?

Posted 09/08/26
What is the optimal vaccine schedule for children?

Posted 08/14/26
Does blocking NLRP3 and RIPK1/RIPK3 prevent both ferroptosis and necroptosis in radiation brain injury?

Posted 07/30/26
What is the current evidence for GLP1 receptor agonists as disease modifying agents in multiple sclerosis, beyond metabolic and weight effects?

Posted 06/09/26
What are recent machanism of actions, minmum duration of years of heat exposure and minimum temperature required for various heat induced skin cancers, also opnion for Kangri Cancer to be answered

Answered 07/30/26
Browse All Pings

Type

Public

Status

Published

Bounty

1 Ping Credit

Created

09/08/2026

Answer Count

0

Vote Count

0

Creator

Ioannis K. Toliopoulos

Tags

Carcinogenesis Immunology Molecular Biology Oncology Pharmacology